Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.6500
-0.0450 (-6.47%)
At close: Mar 28, 2025, 4:00 PM
0.6200
-0.0300 (-4.62%)
After-hours: Mar 28, 2025, 7:53 PM EST
Calidi Biotherapeutics Stock Forecast
CLDI's stock price has decreased by -88.55% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Calidi Biotherapeutics stock have an average target of 15, with a low estimate of 10 and a high estimate of 20. The average target predicts an increase of 2,207.69% from the current stock price of 0.65.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 27, 2024.
Analyst Ratings
The average analyst rating for Calidi Biotherapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +1,438.46% | Jun 27, 2024 |
| Baird | Baird | Buy Maintains $45 → $20 | Buy | Maintains | $45 → $20 | +2,976.92% | May 15, 2024 |
| Baird | Baird | Buy Maintains $90 → $45 | Buy | Maintains | $90 → $45 | +6,823.08% | Mar 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $110 → $20 | Strong Buy | Maintains | $110 → $20 | +2,976.92% | Mar 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $110 | Strong Buy | Initiates | $110 | +16,823.08% | Nov 22, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.77
from -17.30
EPS Next Year
-0.79
from -3.77
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -3.06 | -0.70 | -0.36 |
| Avg | -3.77 | -0.79 | -0.53 |
| Low | -4.39 | -0.86 | -0.68 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.